Europe · Agences & temps réel · Reuters Business

India's Torrent Pharma's profit slips as R&D costs outweigh domestic demand

Publié par Reuters Business · Royaume-Uni il y a 9 h

Indian drugmaker Torrent Pharmaceuticals reported a near 10% decline in second-quarter profit on Friday, as higher spending on ‌research and development outpaced robust demand…

Lire l'article complet sur Reuters Business Connectez-vous pour sauvegarder

MarketNews présente le titre et le résumé publiés par le média. L'article complet se lit sur le site de l'éditeur. (www.reuters.com)

India's Torrent Pharma's profit slips as R&D costs outweigh domestic demand

À lire aussi

Henkell Freixenet renforce sa production de vins effervescents désalcoolisés haut de gamme grâce à l’Aroma Recovery System de Solos

Tsunami warning issued for Sicily following tremors — newspaper

Türkiye urges stronger financing partnerships to turn COP31 pledges into investment

First Russian diesel from Putin-Trump deal heading for US, data shows

Ready for a French test?: Five questions for the ECB

South32 aprova venda à Alcoa e deixa fundição moçambicana Mozal de fora

India's Torrent Pharma's profit slips as R&D costs outweigh domestic demand

Partager

À lire aussi

Henkell Freixenet renforce sa production de vins effervescents désalcoolisés haut de gamme grâce à l’Aroma Recovery System de Solos

Tsunami warning issued for Sicily following tremors — newspaper

Türkiye urges stronger financing partnerships to turn COP31 pledges into investment

First Russian diesel from Putin-Trump deal heading for US, data shows

Ready for a French test?: Five questions for the ECB

South32 aprova venda à Alcoa e deixa fundição moçambicana Mozal de fora